Clinical Trial Update: Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer

View source ↗

Summary

This clinical trial update describes an independent, external, blinded retrospective validation of an AI-based prognostic assay for ER-positive/HER2-negative ea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: Spotlight Medical | Conditions: Breast Cancer, Early Breast Cancer | Status: ACTIVE_NOT_RECRUITING